Company news

Share this article:
Valeant Pharmaceuticals has announced a definitive agreement to acquire Dow Pharmaceutical Sciences, a privately held dermatology company, for $285 million. Dow Pharmaceutical Sciences' current annualized revenues are approximately $45 million, of which roughly $20 million represents royalty payments from licensed products.
 
Wyeth will cut 276 workers in Puerto Rico as a result of decreasing demand for locally manufactured products. The layoffs will be completed by February 2009, with 2,700 workers remaining across three plants in the US Caribbean territory, the AP reported.
 
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.